
On Wednesday, June 23, the US House of Representatives Judiciary Committee approved five antitrust bills, three of them aimed at Big Tech, and took up the last and most aggressive proposed legislation on Thursday. This last is a bill that could require platforms to sell off lines of business.
The debate was extended and began midmorning on Wednesday and stretched into early on Thursday, lawmakers voted to approve a measure that would prohibit platforms like Amazon from disadvantaging rivals who use their platform.
According to Reuters, it also voted to accept a measure that would require big tech companies contemplating mergers to show that they are legal, rather than requiring antitrust enforcers to prove that they are not.
Jerrold Nadler, Committee Chairman said the bills were needed to protect an open internet that has “delivered enormous benefits to Americans and our economy.”
“A small set of online platforms have become gatekeepers for much of the digital marketplace,” he said. “These dominant platforms can have the incentive and ability to abuse their market power to pick winners and losers among the firms that rely on their platforms to reach users and customers.”
When the committee resumes work, it will take up what some call the “break ’em up” bill. This would require a platform, again like Amazon, to sell any business that competes with other businesses using its platform.
There has been vociferous opposition to that bill and others, including from the US Chamber of Commerce, Amazon, Apple, Facebook, and Google.
The committee also approved a bill that would increase the budgets of the agencies enforcing antitrust law. A companion measure has already passed the Senate.
The panel additionally approved measures to require platforms to allow users to transfer their data elsewhere and to ensure that antitrust cases brought by state attorneys general remain in the court they select.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas